Galectin-3, a β-galactoside–binding protein that is upregulated in multiple types of cancers including breast, was found to promote β-catenin/Wnt signaling in tongue squamous cell carcinoma and breast cancer cells (30). The gene discussed is LGALS3; the disease is breast carcinoma.